Many global, regional, and local vendors characterize the breast biopsy market. The market is highly competitive, with all the players competing to gain market share. Intense competition, rapid advances in technology, frequent changes in government policies, and environmental regulations are key factors that confront market growth. The vendors compete based on cost, product quality, reliability, and government regulations. Vendors must provide cost-efficient, high-quality polyamide products to survive and succeed in an intensely competitive market.
The market vendors’ growth depends on market conditions, government support, and industry development. Thus, the vendors should focus on expanding geographically and improving services. Leica Biosystems, C.R. Bard Inc., NuVue Therapeutics, Argon Medical Devices, Inc., Becton, Dickinson and Company, Devicor Medical Products Inc., Hologic Inc., Medtronic PLC, Cook Medical Incorporated, Planmed OY, and others are the major companies in the market which compete in terms of availability, quality, price, and technology. They primarily focus on the development of breast biopsy products. Although international players dominate the market, regional and foreign players with small market shares also have a presence. The international players may strengthen their presence worldwide through acquisitions during the forecast period. It has also been forecast that improvement of the global economic scenario, combined with efforts to enhance infrastructure in emerging nations, is fueling the market growth, thereby making it an ideal time to launch new products of breast biopsy and increase the global market share.
Threat of New Entrants
The threat of new entrants in the breast biopsy market is moderate. Any company manufacturing breast biopsy is required to accept and abide by the mandatory regulatory standards set by the respective regulatory authorities of a country, such as the United States Food and Drug Administration (FDA), European Medicines Agency (EMA), The Central Drugs Standard Control Organization (CDSCO), and others. However, huge opportunities in the market have encouraged many players to invest in this lucrative market. Moreover, supportive government policies and a rising number of investors have impulse entrepreneurs to enter the handheld surgical device industry. These factors are responsible for minimizing the entry barriers for new players, which can be a major threat to the current companies.
Bargaining Power of Suppliers
The global breast biopsy market suppliers are the developers and manufacturers of breast biopsy such as forceps, retractors, graspers, and others used in various general surgical procedures. The bargaining power of suppliers is a crucial factor in the breast biopsy market and determines the industry's strength. Many suppliers are currently present in the market due to the high demand for breast biopsy and increasing government support. The existing key companies capture significant market share and monitor the costs of breast biopsy. The switching cost of these suppliers is moderate because suppliers tend to enter long-term associations, partnerships, and deals with other handheld surgical device manufacturing companies. Thus, the overall bargaining power of suppliers in the global breast biopsy market is expected to be moderate during the forecast period.
Threat of Substitutes
Breast Biopsy are reliable, cost-effective products such as scalpels, forceps, retractors, and others used in various general surgical procedures. Furthermore, many large and medium-scale companies manufacture different types of products for different application. Some small companies provide their products at low prices to sustain themselves in this highly competitive market. Thus, the overall threat of substitutes in the global breast biopsy market is expected to be moderate-to-low during the forecast period.
Bargaining Power of Buyers
The global breast biopsy market is characterized by the presence of a large number of buyers. The market for breast biopsy is identified as having a significant customer base, considering the increasing number of patients suffering from chronic diseases and the increasing use of products for various biopsy procedures. However, the buyers tend to use the products that have been provided by the top players irrespective of the pricing. Thus, the bargaining power of buyers is expected to be moderate in the global breast biopsy market during the forecast period.
Intensity of Rivalry
The overall degree of competition in the global breast biopsy market is high. The reserved degree of product differentiation among existing players increases the intensity of rivalry in the market. The companies engaged in manufacturing breast biopsy are developing advanced products for differentiating their brand from the competitors. Additionally, many prominent market players are entering into strategic partnerships, co-development activities, and tie-ups with established companies to overcome the competition. Thus, the intensity of rivalry in the global breast biopsy market is expected to be high during the study period.
